Passage Bio Ownership | Who Owns Passage Bio?
Passage Bio Ownership Summary
Passage Bio is owned by 67.18% institutional investors, 0.49% insiders, and 32.33% retail investors. Orbimed advisors is the largest institutional shareholder, holding 17.98% of PASG shares. Worldwide Healthcare Ord is the top mutual fund, with 3.38% of its assets in Passage Bio shares.
PASG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Passage Bio | 67.18% | 0.49% | 32.33% |
| Sector | Healthcare Stocks | 46.62% | 8.13% | 45.25% |
| Industry | Biotech Stocks | 44.91% | 7.98% | 47.11% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 10.12M | 17.98% | $8.04M |
| Vestal point capital, lp | 6.05M | 10.75% | $4.81M |
| Lynx1 capital management lp | 5.06M | 8.98% | $4.02M |
| New leaf venture partners | 2.50M | 4.44% | $1.98M |
| Vanguard group | 2.07M | 3.68% | $1.65M |
| Tang capital management | 1.50M | 2.66% | $1.19M |
| Renaissance | 1.13M | 2.00% | $893.93K |
| Acadian asset management | 961.27K | 1.71% | $762.00K |
| Blackrock | 817.53K | 1.45% | $649.28K |
| Millennium management | 750.93K | 1.33% | $596.38K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 2.50M | 2.41% | $1.98M |
| Vestal point capital, lp | 6.05M | 0.36% | $4.81M |
| Lynx1 capital management lp | 5.06M | 0.26% | $4.02M |
| Orbimed advisors | 10.12M | 0.16% | $8.04M |
| Tang capital management | 1.50M | 0.12% | $1.19M |
| Dlk investment management | 64.00K | 0.02% | $50.83K |
| Bridgeway capital management | 556.14K | 0.01% | $441.69K |
| Rbf capital | 142.81K | 0.01% | $113.42K |
| Fiduciary trust | 215.00K | 0.00% | $170.75K |
| Acadian asset management | 961.27K | 0.00% | $762.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 6.05M | 0.36% | 1.55M |
| Lynx1 capital management lp | 5.06M | 0.26% | 211.76K |
| Geode capital management | 431.11K | - | 46.83K |
| Tower research capital llc (trc) | 13.20K | 0.00% | 13.17K |
| Ubs group | 1.15K | - | 1.15K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Versant venture management | - | - | -4.03M |
| Acuitas investments | - | - | -471.81K |
| Affinity asset advisors | - | - | -264.27K |
| Two sigma advisers, lp | - | - | -209.60K |
| Pale fire capital se | - | - | -141.44K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Harbour investments | 60.00 | - | 60.00 | $48.00 |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -4.00 |
| Federation des caisses desjardins du quebec | -10.00 |
| Advisor group | -217.00 |
| Wells fargo & company/mn | -309.00 |
| Global retirement partners | -400.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 44 | -12.00% | 37,821,661 | -0.07% | 67 | 1.42% | 11 | -45.00% | 11 | -15.38% |
| Mar 31, 2024 | 50 | - | 37,847,261 | 27.02% | 68 | 2.33% | 20 | -4.76% | 13 | 30.00% |
| Dec 31, 2023 | 50 | 2.04% | 29,797,319 | -0.77% | 54 | 1.80% | 21 | 40.00% | 10 | -23.08% |
| Sep 30, 2023 | 49 | -9.26% | 30,028,681 | -3.78% | 54 | 1.68% | 15 | -6.25% | 13 | -27.78% |
| Jun 30, 2023 | 54 | -3.57% | 31,206,832 | -8.17% | 57 | 1.48% | 16 | -15.79% | 18 | 20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Worldwide Healthcare Ord | 2.09M | 3.38% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.50M | 2.42% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 493.23K | 0.80% | - |
| Bridgeway Ultra-Small Company | 416.04K | 0.67% | - |
| Galileo - Biotech Innovation Fund S USD | 412.28K | 0.67% | - |
| Fidelity Extended Market Index | 300.98K | 0.49% | 42.73K |
| Bridgeway Ultra-Small Company Market | 140.10K | 0.23% | - |
| iShares Micro-Cap ETF | 128.72K | 0.21% | - |
| BlackRock Extended Equity Market K | 75.13K | 0.12% | -32.00 |
| Fidelity Series Total Market Index | 69.59K | 0.11% | 25.46K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 19, 2024 | ORBIMED ADVISORS LLC | - | Sell | $27.90K |
| Sep 17, 2024 | ORBIMED ADVISORS LLC | - | Sell | $81.32K |
| Sep 16, 2024 | ORBIMED ADVISORS LLC | - | Sell | $46.69K |
| Sep 18, 2024 | ORBIMED ADVISORS LLC | - | Sell | $18.71K |
| Feb 13, 2024 | Borthwick Kathleen | SVP, INTERIM CFO | Sell | $1.43K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | 4 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 5 |
| 2023 Q4 | - | - |
| 2023 Q3 | - | 1 |
PASG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools